Andrew Huberman, Ph.D., neuroscientist and tenured associate professor of neurobiology and ophthalmology at Stanford University School of Medicine, is the newest member of the Lung Health Institute’s advisory board.
Responsible for shedding light on scientific findings in academic literature and how those findings could potentially evolve research and clinical practices at Lung Health Institute, Dr. Huberman brings more than 20 years’ experience in neurobiology to the board. He and the other board members will guide research efforts aimed at accelerating the advancement of chronic lung disease treatments.
Lung Health Institute — whose five clinics around the country include one in Scottsdale — leads the industry in regenerative medicine and is among the first cellular therapy providers accredited by The Joint Commission, widely considered the gold standard of quality patient care.
